Age-associated declines in perforin secretion capacity, reduced CD94 receptor expression, and diminished cytotoxic activity of NK cells may attenuate neuroinflammation and decelerate autoimmune processes in MS. This evidence concerns the gene PRF1 and myeloid sarcoma.